Sesen Bio Operating Income

Sesen Bio (SESN) currently reports a operating income of $110M as of September 2025. That compares with $-41M in the prior-year period — up 369.3% year over year. Use the charts on this page to explore Sesen Bio's operating income history and peer comparisons.

Sesen Bio's operating income increased from $-41M to $110M — a 369.3% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sesen Bio reported $110M in operating income as of September 2025. That compares with $-41M in the prior-year period — up 369.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sesen Bio, and consider following SESN for alerts when major investors trade the stock.

Sesen Bio is classified in the Healthcare sector. On operating income, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SESN with unrelated industries.